Table 1.
Patient characteristics and endoscopic data.
Fig 1.
MIC distributions of common used antibiotics in H. pylori in South China.
Arrows indicates the EUCAST (↓) or other (⇣) resistance breakpoint. A is for amoxicillin (AMX), B is for clarithromycin (CLA), C is for metronidazole (MTZ), D is for levofloxacin (LEV), E is for tetracycline (TET), F is for furazolidone (FZD).
Table 2.
Minimum inhibitory concentrations (MICs) of H. pylori to commonly used antibiotics (mg/L).
Table 3.
Differences in resistance rates of H. pylori using different breakpoints.
Table 4.
Differences in multiple antibiotic resistance rates of H. pylori using different breakpoints.
Fig 2.
Impact of disease on different antibiotic resistance of H. pylori in South China.
A is for amoxicillin (AMX), B is for clarithromycin (CLA), C is for furazolidone (FZD), D is for levofloxacin (LEV), E is for metronidazole (MTZ), F is for tetracycline (TET). CSG: chronic superficial gastritis; CAG: chronic atrophic gastritis; EG: erosive gastritis; PU: peptic ulcer.
Fig 3.
Impact of age on different antibiotic resistance of H. pylori in South China.
A is for amoxicillin (AMX), B is for clarithromycin (CLA), C is for furazolidone (FZD), D is for levofloxacin (LEV), E is for metronidazole (MTZ), F is for tetracycline (TET).
Fig 4.
Impact of gender on different antibiotic resistance of H. pylori in South China.
A is for amoxicillin (AMX), B is for clarithromycin (CLA), C is for furazolidone (FZD), D is for levofloxacin (LEV), E is for metronidazole (MTZ), F is for tetracycline (TET).